What we’re reading, December 8, 2016: Senate overwhelmingly passes the 21st Century Cures Act, sending it to President Obama for approval; Surgeon General issues a report calling for action to reduce e-cigarette use by young people; soaring costs of naloxone may hinder efforts to prevent opioid overdoses.
The Senate voted 94-5 in favor of the 21st Century Cures Act, the sweeping bill that will fund National Institutes of Health research, mental illness and substance abuse treatment, and FDA reform. Senator Lamar Alexander, R-Tennessee, called the bill’s passage “a Christmas miracle…that will help virtually every American family.” The legislation now heads to President Barack Obama, who has vowed to sign it into law as soon as it reaches his desk.
A new report from the Surgeon General calls the use of e-cigarettes among youth and young adults a “major public health concern.” The Call to Action includes steps like regulating e-cigarette marketing and sponsoring media campaigns to educate the public on the dangers of e-cigarettes, especially for young people. “Although we continue to learn more about e-cigarettes with each passing day, we currently know enough to take action to protect our nation’s young people from being harmed by these products,” wrote Surgeon General Vivek H. Murthy, MD, in the report’s preface.
Efforts to prevent opioid overdoses may face a barrier in the rising price of naloxone, according to a research letter in the New England Journal of Medicine. For example, a 2-dose package of Evzio, the auto-injector formulation of naloxone, cost $690 in 2014 but now sells for $4500. The authors state that legislative efforts to expand naloxone availability “should explicitly call on manufacturers to reduce the price of naloxone and increase transparency regarding their costs.”
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More